<DOC>
	<DOCNO>NCT01434784</DOCNO>
	<brief_summary>The European Organisation Research Treatment Cancer Quality Life Questionnaire Lung Cancer 13 ( EORTC QLQ-LC13 ) consider standard instrument ass quality life ( QL ) lung cancer patient . Since publication 1994 , major clinical advance make . The research objective develop revise lung cancer module ( ) cover QL aspect relevant context newly available diagnostic therapeutic option , ( b ) applicable non-metastatic metastatic cancer , ( c ) cover QL aspect generally relevant patient lung cancer miss original module . This project comprise first three project phase accord Module Development Manual ( www.eortc.be/qol ) .</brief_summary>
	<brief_title>Update EORTC QLQ-LC13 Quality Life Questionnaire</brief_title>
	<detailed_description>The project follow EORTC model module development cover first three phase : Phase I This phase aim compile extensive list quality life issue relevant lung cancer patient . The following source use : ( 1 ) exist questionnaire lung cancer respiratory illness , ( 2 ) literature , ( 3 ) investigator 's brochure ( IB ) new drug , ( 4 ) interview health care professional patient . Phase II Phase I data provide information issue include improved lung cancer module . These issue convert item follow EORTC format four point response scale range `` '' `` much '' . For sake consistency whenever possible , item exist QLC-LC13 used item take Item Bank currently include 6.000 item . After stage , procedure formally peer-reviewed EORTC QLG Module Development Committee . After approval , provisional list item ready Phase III . Phase III The provisional lung cancer module pre-tested international group patient lung cancer . Patients first ask fill QLQ-C30 provisional revise lung cancer module . After complete form , patient interview regard revise lung cancer module . The interview identify questionnaire item patient find annoying , confuse upsetting . A issue relevance : patient indicate whether issue find irrelevant whether issue yet include provisional module need add . The interviewer , either physician study nurse , record patient ' comment debrief questionnaire . The sample matrix specifies three main group accord primary therapy either surgery , radiochemotherapy target therapy . The singular use combination therapy yield nine subgroups patient : 1.1 Surgery alone 1.2 Surgery combination therapy 1.3 Surgery ( late effect ) 2.1 Chemotherapy alone 2.2 Radiotherapy alone 2.3 Sequential radiochemotherapy 2.4 Concurrent radiochemotherapy 3.1 Targeted therapy alone 3.2 Targeted therapy combination therapy The recruitment goal n = 15 per subgroup , result total 135 patient . Recruitment take place follow study region : English speaking country include United Kingdom Australia ; Northern Europe include Norway Germany ; Southern Europe include Italy Spain ; Eastern Europe , one non-European country ( e.g. , Taiwan ) .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>confirm diagnosis lung cancer inform consent capability respond questionnaire follow interview inform consent lack capability respond questionnaire</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>lung cancer</keyword>
	<keyword>quality life</keyword>
</DOC>